Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.
Clinical trial NCT02738918 · COMPLETED
Trial details
- NCT number
- NCT02738918
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-09-18
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.